Patents by Inventor Kevin D. Lustig

Kevin D. Lustig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Facilitating a Transaction between a Client and a Life Science Research Service Provider
    Publication number: 20090099868
    Abstract: Disclosed herein are methods of facilitating transactions between clients and life science research service providers.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 16, 2009
    Applicant: The Assay Depot, Inc.
    Inventors: Kevin D. Lustig, Andrew Martin, Christopher L. Petersen
  • Assay for identifying extracellular signaling proteins
    Patent number: 5866098
    Abstract: The present invention concerns a novel paracrine signaling assay.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: February 2, 1999
    Assignee: President and Fellows of Harvard College
    Inventors: Kevin D. Lustig, Marc W. Kirschner
  • Method of inhibiting cell growth with the P.sub.2U receptor
    Patent number: 5691156
    Abstract: Isolated DNAs encoding the human P.sub.2U receptor are disclosed, along with vectors and host cells containing the same and methods of using the same. Host cells which are essentially free of endogenous P.sub.2U receptor expression, and which express a heterologous P.sub.2U receptor such as a murine P.sub.2U receptor, are also disclosed, along with methods of using the same.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: November 25, 1997
    Assignees: The University of North Carolina at Chapel Hill, The Curators of the University of Missouri
    Inventors: Richard C. Boucher, Gary A. Weisman, John T. Turner, Thomas K. Harden, Claude E. Parr, Daniel M. Sullivan, Laura J. Erb, Kevin D. Lustig
  • Method of expression cloning
    Patent number: 5654150
    Abstract: The present invention provides improvements in the expression cloning method for isolating novel cDNA clones. In particular, in the expression cloning method comprising the steps of preparing a cDNA library from a cell that expresses a desired protein; inserting the cDNA library into an expression vector; inserting the cDNA library into bacterial cells and culturing the bacterial cells to produce individual bacterial colonies; collecting pools of a predetermined number of individual bacterial colonies; isolating the cDNAs contained in the pools; expressing proteins encoded by the cDNAs; and detecting the desired protein, positive clones may be efficiently and cost-effectively obtained by collecting pools of about 100 individual bacterial colonies and expressing proteins encoded by the cDNAs in the pools in vitro.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 5, 1997
    Assignees: President and Fellows of Harvard College, Harvard University, Office of Technology and Trademark Licensing
    Inventors: Randall W. King, Kevin D. Lustig, P. Todd Stukenberg, Marc W. Kirschner
  • Methods of detecting compounds which bind to the P.sub.2U receptor
    Patent number: 5607836
    Abstract: Isolated DNAs encoding the human P.sub.2U receptor are disclosed, along with vectors and host cells containing the same and methods of using the same. Host cells which are essentially free of endogenous P.sub.2U receptor expression, and which express a heterologous P.sub.2U receptor such as a murine P.sub.2U receptor, are also disclosed, along with methods of using the same.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: March 4, 1997
    Assignee: The Curators of the University of Missouri
    Inventors: Richard C. Boucher, Gary A. Weisman, John T. Turner, Thomas K. Harden, Claude E. Parr, Daniel M. Sullivan, Laura J. Erb, Kevin D. Lustig
  • DNA Encoding the human P.sub.2U receptor and null cells expressing P.sub.2U receptors
    Patent number: 5596088
    Abstract: Isolated DNAs encoding the human P.sub.2U receptor are disclosed, along with vectors and host cells containing the same and methods of using the same. Host cells which are essentially free of endogenous P.sub.2U receptor expression, and which express a heterologous P.sub.2U receptor such as a murine P.sub.2U receptor, are also disclosed, along with methods of using the same.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: January 21, 1997
    Assignees: The University of North Carolina At Chapel Hill, The Curators of the University of Missouri
    Inventors: Richard C. Boucher, Gary A. Weisman, John T. Turner, Thomas K. Harden, Claude E. Parr, Daniel M. Sullivan, Laura J. Erb, Kevin D. Lustig
  • Assay for identifying extracellular signaling proteins
    Patent number: 5585087
    Abstract: The present invention concerns a novel paracrine signaling assay.
    Type: Grant
    Filed: June 8, 1994
    Date of Patent: December 17, 1996
    Assignee: President and Fellows of Harvard College
    Inventors: Kevin D. Lustig, Marc W. Kirschner